Civic AI
Procurement intelligence
Federal contract award
ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE.
ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) · Department of Health and Human Services
- Value
- $147,062,009
- Start
- Sep 26, 2019
- End
- Sep 30, 2027
- Action date
- May 11, 2026
- PIID
- 75A50119C00055
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- WASHINGTON, DC
- Award type
- DEFINITIVE CONTRACT
Description
ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE.
Need modifications, related awards, and vendor peers? Open the full award workspace.